Xencor, Inc. · NASDAQ:XNCR
BVF PARTNERS L P/IL reported a 6.50% stake in Xencor, Inc. (Schedule 13G)
Event Oct 9, 2025 · Filed Oct 17, 2025
BVF PARTNERS L P/IL reported a 6.50% stake in Xencor, Inc., 4,619,341 shares, as a passive investor on Oct 9, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 6.50%
- Shares
- 4,619,341
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.50% | 2,467,127 |
| BVF I GP LLC | 3.50% | 2,467,127 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.50% | 1,793,209 |
| BVF II GP LLC | 2.50% | 1,793,209 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 286,542 |
| BVF Partners OS Ltd. | 0.40% | 286,542 |
| BVF GP HOLDINGS LLC | 6.00% | 4,260,336 |
| BVF PARTNERS L P/IL | 6.50% | 4,619,341 |
| BVF INC/IL | 6.50% | 4,619,341 |
| LAMPERT MARK N | 6.50% | 4,619,341 |
Source
Related
- Xencor, Inc.
- Biotechnology Value Fund L P
- Xencor, Inc. shareholders
- Schedule 13G/A · Biotechnology Value Fund L P · Feb 17, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Feigal Ellen · Jul 8, 2026
- Form 4 · Gorman Kevin Charles · Jul 8, 2026
- Form 4 · Gustafson Kurt A · Jul 8, 2026
- Form 4 · Klencke Barbara · Jul 8, 2026